Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
PMV Pharmaceuticals, Inc.
- License Information
-
More Information
Article History
Received: 17 April 2025
Revised: 23 June 2025
Accepted: 9 July 2025
First Online: 23 July 2025
Competing interests
: The authors declare the following competing interests. SK is a local PI, with institutional, financial interest, and trial funding from PMV Pharmaceuticals. MF is an employee of PMV Pharmaceuticals with stock options. AJL was a co-founder of, and is a board member and consultant for, PMV Pharmaceuticals. He has received stock, options, and fees from PMV Pharmaceuticals for his services.
